Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function

被引:542
作者
Basso, AD
Solit, DB
Chiosis, G
Giri, B
Tsichlis, P
Rosen, N
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Thomas Jefferson Univ, Kimmel Canc, Philadelphia, PA 19107 USA
[4] Cornell Univ, Weill Grad Sch Med Sci, Program Pharmacol, Philadelphia, PA 19107 USA
关键词
D O I
10.1074/jbc.M206322200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hsp90 is a chaperone required for the conformational maturation of certain signaling proteins including Raf, cdk4, and steroid receptors. Natural products and synthetic small molecules that bind to the ATP-binding pocket in the amino-terminal domain of Hsp90 inhibit its function and cause the degradation of these client proteins. Inhibition of Hsp90 function in cells causes down-regulation of an Akt kinase-dependent pathway required for D-cyclin expression and retinoblastoma protein-dependent G, arrest. Intracellular Akt is associated with Hsp90 and Cdc37 in a complex in which Akt kinase is active and regulated by phosphatidylinositol 3-kinase. Functional Hsp90 is required for the stability of Akt in the complex. Occupancy of the ATP-binding pocket by inhibitors is associated with the ubiquitination of Akt and its targeting to the proteasome, where it is degraded. This results in a shortening of the half-life of Akt from 36 to 12 h and an 80% reduction in its expression. Akt and its activating kinase, PDK1, are the only members of the protein kinase A/protein kinase B/protein kinase C-like kinase family that are affected by Hsp90 inhibitors. Thus, transduction of growth factor signaling via the Akt and Raf pathways requires functional Hsp90 and can be coordinately blocked by its inhibition.
引用
收藏
页码:39858 / 39866
页数:9
相关论文
共 63 条
  • [31] Page C, 2000, ANTICANCER RES, V20, P407
  • [32] Page C, 2000, INT J ONCOL, V17, P23
  • [33] THE UBIQUITIN-PROTEASOME PATHWAY IS REQUIRED FOR PROCESSING THE NF-KAPPA-B1 PRECURSOR PROTEIN AND THE ACTIVATION OF NF-KAPPA-B
    PALOMBELLA, VJ
    RANDO, OJ
    GOLDBERG, AL
    MANIATIS, T
    [J]. CELL, 1994, 78 (05) : 773 - 785
  • [34] Steroid receptor interactions with heat shock protein and immunophilin chaperones
    Pratt, WB
    Toft, DO
    [J]. ENDOCRINE REVIEWS, 1997, 18 (03) : 306 - 360
  • [35] Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone
    Prodromou, C
    Roe, SM
    OBrien, R
    Ladbury, JE
    Piper, PW
    Pearl, LH
    [J]. CELL, 1997, 90 (01) : 65 - 75
  • [36] INHIBITORS OF THE PROTEASOME BLOCK THE DEGRADATION OF MOST CELL-PROTEINS AND THE GENERATION OF PEPTIDES PRESENTED ON MHC CLASS-I MOLECULES
    ROCK, KL
    GRAMM, C
    ROTHSTEIN, L
    CLARK, K
    STEIN, R
    DICK, L
    HWANG, D
    GOLDBERG, AL
    [J]. CELL, 1994, 78 (05) : 761 - 771
  • [37] Modulation of Akt kinase activity by binding to Hsp90
    Sato, S
    Fujita, N
    Tsuruo, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) : 10832 - 10837
  • [38] Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
    Schneider, C
    SeppLorenzino, L
    Nimmesgern, E
    Ouerfelli, O
    Danishefsky, S
    Rosen, N
    Hartl, FU
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) : 14536 - 14541
  • [39] Schulte TW, 1996, MOL CELL BIOL, V16, P5839
  • [40] Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO